MANERIX

This brand name is authorized in Canada, Spain, Ireland, Malta, United Kingdom

Active ingredients

The drug MANERIX contains one active pharmaceutical ingredient (API):

1 Moclobemide UNII PJ0Y7AZB63 - MOCLOBEMIDE

Moclobemide is an antidepressant which affects the monoaminergic cerebral neurotransmitter system by means of a reversible inhibition of monoamine oxidase preferentially of type A (RIMA). Read about Moclobemide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MANERIX Film-coated tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06AG02	Moclobemide	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AG Monoamine oxidase A inhibitors
Discover more medicines within N06AG02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 00899356, 02166747
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 59169, 60824
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 26338, 26358, 373837, 373958
Country: IE	Health Products Regulatory Authority	Identifier(s): 34312, 63384
Country: MT	Medicines Authority	Identifier(s): AA565/74401